NCT02421380View on ClinicalTrials.gov

Characterization of Hyperpolarized Pyruvate MRI Reproducibility

NARecruitingINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Malignant Solid Tumors
Interventions
DRUG

Hyperpolarized Pyruvate

Trial Locations (2)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

07645

RECRUITING

Memorial Sloan Kettering Bergen (Consent only ), Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER